Fertility and Sterility
Volume 79, Issue 1 , Pages 112-119, January 2003

The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life☆

  • Gaylene Pron, Ph.D.

      Affiliations

    • Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • Center for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Gaylene Pron, Ph.D., Department of Public Health Sciences, Faculty of Medicine, University of Toronto, 100 College St., Room 513, Banting Building, Toronto, Ontario M5G 1L5, Canada (FAX: 416-971-2240).
    • ,
  • Marsha Cohen, M.D.

      Affiliations

    • Center for Research in Women’s Health, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • ,
  • Jennifer Soucie, M.Sc.

      Affiliations

    • Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Greg Garvin, M.D.

      Affiliations

    • Department of Radiology, St. Joseph’s Health Care, London, Ontario, Canada
    • ,
  • Leslie Vanderburgh, M.D.

      Affiliations

    • Department of Radiology, William Osler Health Center, Brampton, Ontario, Canada
    • ,
  • Stuart Bell, M.D.

      Affiliations

    • Department of Medical Imaging, Sunnybrook and Women’s College Health Sciences Center, Toronto, Ontario, Canada
    • ,
  • Ontario Uterine Fibroid Embolization Collaborative Group

Received 19 April 2002; received in revised form 16 September 2002; accepted 16 September 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The Ontario Uterine Fibroid Embolization Trial was funded in part by the Boston Scientific Corporation.

PII: S0015-0282(02)04539-9

Fertility and Sterility
Volume 79, Issue 1 , Pages 112-119, January 2003

Article Tools

* Image Usage & Resolution